About Pegasus Farmaco
Pegasus Farmaco is a company based in Hyderabad (India) founded in 1995. Pegasus Farmaco has raised $87.48 thousand across 1 funding round from investors including Surender Vuthoori, Indira Vuthoori and Neeraja Beti. The company has 127 employees as of April 03, 2024. Pegasus Farmaco operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hyderabad, India
- Employees 127 as on 03 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pegasus Farmaco (India) Private Limited
- Date of Incorporation 18 Oct, 1995
- Jurisdiction Andhra Pradesh, Telangana, India
-
Annual Revenue
$4.46 M (USD)-34.27as on Mar 31, 2021
-
Net Profit
$68.82 K (USD)-12.97as on Mar 31, 2021
-
EBITDA
$445.52 K (USD)-2.67as on Mar 31, 2021
-
Total Equity Funding
$87.48 K (USD)
in 1 rounds
-
Latest Funding Round
$87.48 K (USD), Angel Round
Mar 31, 2016
-
Investors
& 3 more
-
Employee Count
127
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pegasus Farmaco
Pegasus Farmaco has successfully raised a total of $87.48K through 1 strategic funding round. The most recent funding activity was a Angel Round of $87.48 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pegasus Farmaco
Pegasus Farmaco has secured backing from 4 investors, including angel investors. Prominent investors backing the company include Surender Vuthoori, Indira Vuthoori and Neeraja Beti.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SV
Surender Vuthoori |
-
|
Locked | Locked | Locked |
|
IV
Indira Vuthoori |
-
|
Locked | Locked | Locked |
|
NB
Neeraja Beti |
-
|
Locked | Locked | Locked |
Investor details for Pegasus Farmaco
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pegasus Farmaco
Investment portfolio details for Pegasus Farmaco
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pegasus Farmaco
Detailed financials for Pegasus Farmaco
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pegasus Farmaco Comparisons
Peer comparison for Pegasus Farmaco
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pegasus Farmaco
Pegasus Farmaco operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Pegasus Farmaco
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pegasus Farmaco
Complete news archive for Pegasus Farmaco
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pegasus Farmaco
Pegasus Farmaco was founded in 1995 and raised its 1st funding round 21 years after it was founded.
Pegasus Farmaco is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Pegasus Farmaco is a funded company, having raised a total of $87.48K across 1 funding round to date.
As of Apr 03, 2024, the latest employee count at Pegasus Farmaco is 127.
Annual revenue of Pegasus Farmaco is $4.46M as on Mar 31, 2021.
Pegasus Farmaco was founded in 1995 and is based in Hyderabad, India. Operations focus on the pharmaceutical sector, where capsules, tablets, syrups, drops, ointments, and injectables are produced across therapeutic categories such as antibiotics, analgesics, antipyretics, and muscle relaxants. Manufacturing facilities are certified under WHO-GMP standards and ISO 9001:2008, ensuring compliance with quality requirements.
Pegasus Farmaco's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Pegasus Farmaco has 4 investors. Key investors include Surender Vuthoori, Indira Vuthoori, Neeraja Beti, and Raghuveer Beti.
The valuation of Pegasus Farmaco is $1.46M as of Mar 2016.